![Gregory N. Dietsch](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Gregory N. Dietsch
Director Técnico/Científico/I+D en VentiRx Pharmaceuticals, Inc. .
Cargos activos de Gregory N. Dietsch
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
VentiRx Pharmaceuticals, Inc.
![]() VentiRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology VentiRx Pharmaceuticals, Inc. develops and commercializes novel medicines for the treatment of cancer, respiratory, and inflammatory diseases. It focuses on the development of novel small molecule product candidates targeting toll-like receptor 8 for applications in oncology, allergy, autoimmune, and inflammatory diseases. The company was founded by Michael J. Kamdar and Robert Hershberg on June 12, 2006 and is headquartered in Seattle, WA. | Director Técnico/Científico/I+D | - | - |
American Board of Toxicology | Corporate Officer/Principal | - | - |
Historial de carrera de Gregory N. Dietsch
Antiguos cargos conocidos de Gregory N. Dietsch.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
ICOS Corp.
![]() ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Corporate Officer/Principal | - | - |
Formación de Gregory N. Dietsch.
Washington State University | Graduate Degree |
Oregon Health & Science University | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 6 |
Operativa
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Graduate Degree | 1 |
Sectorial
Health Technology | 3 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 3 |
---|---|
VentiRx Pharmaceuticals, Inc.
![]() VentiRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology VentiRx Pharmaceuticals, Inc. develops and commercializes novel medicines for the treatment of cancer, respiratory, and inflammatory diseases. It focuses on the development of novel small molecule product candidates targeting toll-like receptor 8 for applications in oncology, allergy, autoimmune, and inflammatory diseases. The company was founded by Michael J. Kamdar and Robert Hershberg on June 12, 2006 and is headquartered in Seattle, WA. | Health Technology |
ICOS Corp.
![]() ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Health Technology |
American Board of Toxicology |
- Bolsa de valores
- Insiders
- Gregory N. Dietsch
- Experiencia